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Abstract
Aortic valve bypass (AVB) has been shown to be a viable solution for patients with severe
aortic stenosis (AS). Under this circumstance, the left ventricle (LV) has a double outlet. The
objective was to develop a mathematical model capable of evaluating the hemodynamic
performance following the AVB surgery. A mathematical model that captures the interaction
between LV, AS, arterial system, and AVB was developed. This model uses a limited num-
ber of parameters that all can be non-invasively measured using patient data. The model
was validated using in vivo data from the literature. The model was used to determine the ef-
fect of different AVB and AS configurations on flow proportion and pressure of the aortic
valve and the AVB. Results showed that the AVB leads to a significant reduction in trans-
valvular pressure gradient. The percentage of flow through the AVB can range from 55.47%
to 69.43% following AVB with a severe AS. LV stroke work was also significantly reduced
following the AVB surgery and reached a value of around 1.2 J for several AS severities.
Findings of this study suggest: 1) the AVB leads to a significant reduction in transvalvular
pressure gradients; 2) flow distribution between the AS and the AVB is significantly affected
by the conduit valve size; 3) the AVB leads to a significant reduction in LV stroke work; and
4) hemodynamic performance variations can be estimated using the model.
Introduction
Aortic stenosis (AS) is the most common valvular disease in the elderly population. Untreated
symptomatic AS is associated with a poor prognosis and significant morbidity. Aortic valve re-
placement (AVR) is currently the standard of care for reducing the left ventricular overload
and improving the quality of life of patients [1]. However, a significant proportion of patients
(around 30% to 60%) are not referred to AVR because they fall within the category of high-risk
patients [2,3,4]. This is typically because of comorbidities, severely calcified aorta (porcelain
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aorta) or narrow LVOT (<18 mm) [5]. Transcatheter aortic valve replacement (TAVI) has re-
cently emerged as a good option for such inoperable patients. However, TAVI might also be
not feasible in all inoperable patients, such as those with porcelain aorta, bicuspid aortic valve,
ostial encroachment or small LVOT, leaving a sub-population of ‘no-option’ patients [6,7].
Furthermore, TAVI and AVR appear to have similar major stroke rates at 30 days and 1 year
(p = 0.20 and p = 0.07, respectively). However, when strokes and transient ischemic events are
considered, AVR showed significantly better results compared to TAVI both at 30 days and 1
year (p = 0.04) [8]. As a consequence, some investigators suggested the use of aortic valve by-
pass (AVB) as an alternative to TAVI or for patients with contraindications to both AVR and
TAVI [9,10,11].
In AVB, also called apico-aortic bypass, the AS and the aorta are never manipulated and a
second outflow tract for blood flow during systolic phase is created by inserting a valved con-
duit at the level of the left ventricle apex. This leads to a double outlet ventricle [12]. The out-
flow conduit is connected to the descending thoracic aorta. The advantages of this approach
are: 1) the calcified aortic valve and the aorta are never manipulated; 2) it is less subjected to
patient-prosthesis mismatch; 3) there is no risk of damage to the ascending aorta or obstruc-
tion of the coronary arteries; 4) it potentially leads to less risks of stroke compared to the AVR.
In AVB, several combinations of conduit size and conduit valve size can be used. An impor-
tant clinical parameter to predict is the proportion of blood flow crossing the native stenotic
valve vs. the bypass conduit. In addition, previous studies [13,14,15] showed that this flow dis-
tribution can be clinically determined using magnetic resonance imaging. Another important
parameter to evaluate is the left ventricle stroke work, representing the work of the left ventricle
during each heart beat, before and following the AVB surgery.
The objective of this study was to develop a mathematical model that can predict the varia-
tion in hemodynamic parameters (mainly transvalvular pressure gradients; flow distribution
between the native aortic valve and the conduit) and left ventricle load following the aortic
valve bypass surgery. The challenge was to develop a model solely based on non-invasive pa-
tient data, characteristics of the conduit (its diameter) and the hemodynamic performance of
the conduit valve (its effective orifice area). We validated the model using existing clinical data
and we provided results allowing a better understanding of the expected hemodynamic out-
comes following the AVB surgery.
Methods
A schematic diagram of the lumped parameter model is presented in Fig 1. The code developed
by Keshavarz-Motamed et al. [16,17] was modified to simulate the AVB. This model includes
four different sub-models: 1) left ventricle (LV) model; 2) AS model; 3) systemic circulation
model; and 4) AVB model. All parameters used in the lumped parameter model are listed
in Table 1.
Heart-Arterial Model
Heart function was described by time varying elastance as the following:
EðtÞ ¼ PLVðtÞ
VðtÞ  V0
ð1Þ
where PLV(t), V(t) and V0 are the LV pressure, the LV volume and the unloaded volume [18],
respectively. The amplitude of E(t) was normalized with respect to maximal elastance Emax,
giving EN(tN) = E(t)/Emax. Time was then normalized with respect to the time to attain peak
elastance, TEmax (tN = t/TEmax). Note that normalized time-varying elastance curves EN(tN)
Aortic Valve Bypass Hemodynamics
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Fig 1. Schematic diagrams. (A) Electrical representation, (B) schematic representation of the lumped
parameter model used to simulate left-sided heart in presence of aortic stenosis and/or apico-aortic conduit
(please see Table 1 for all other parameters used in the lumped parameter model).
doi:10.1371/journal.pone.0123000.g001
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have similar shapes in the normal human hearts with various inotropic situations or for dis-
eased human hearts despite the existence of differences with regard to etiology of cardiovascu-
lar diseases [18,19].
EmaxENðt=TEmaxÞ ¼
PLVðtÞ
VðtÞ  V0
ð2Þ
This normalized curve, represented as a Fourier series [19], can be described mathematical-
ly. Thus, when EN(tN) is given, the relation between PLV(t) and V(t) for any ventricle is deter-
mined. The ventricle is ﬁlled by a normalized physiological mitral ﬂow waveform adjusted for
the total required stroke volume, in this study 75 ml [16,17].
Table 1. Summarized cardiovascular parameters used to simulate all cases.
Description Abbreviation Value Maximum error
(%)*
Ventricular parameters
Left-ventricular end-diastolic volume LVEDV 150 ml
Unstressed volume V0 -15 ml
Maximal elastance Emax Adjusted for stroke volume 75 ml
Time to maximal elastance TEmax 0.24s
Valve parameters
Effective oriﬁce area EOA From AS and AVB data 1.73
Energy loss coefﬁcient ELCo From AS and AVB data 1.98
Variable resistance Rav From AS and AVB data 2.16
Inductance Lav From AS and AVB data 1.18
Systematic circulation parameters
Aortic resistance Rao 0.05 mmHg.s.ml
-1 3.95
Aortic compliance Cao 0.5 ml/mmHg 1.99
Systemic vein resistance RSV 0.05 mmHg.s.ml
-1 2.03
Systemic arteries and veins compliance CSAC 2 ml/mmHg 2.03
systemic arteries resistance (including arteries, arterioles
and capillaries)
RSA 0.8 mmHg.s.ml
-1 1.97
Upper body resistance Rub Adjusted to have 15% of total ﬂow rate in healthy case
(Mcdonald, 1974)
1.98
Proximal descending aorta resistance Rpda 0.05 mmHgsml-1 1.98
Apico aortic conduit
AVB tube resistance RAVB 0.05 mmHgsml-1 1.99
Output condition
Central venous pressure PCV0 4 mmHg
Input condition
Mitral valve mean ﬂow rate Qmv 75 ml
Other
Constant blood density 1050 kg/m3
Cardiac output CO 5.2 l/min
Heart rate HR 70 beats/min
Duration of cardiac cycle T 0.857 s
*Maximum error in computed ratio between AS and AVB ﬂow rates from sensitivity analysis in response to independent variation (±30%) in
each parameter
doi:10.1371/journal.pone.0123000.t001
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Aortic Stenosis Model
The AS was modeled using the analytical formulation for the net pressure gradient (TPGnet)
across the stenotic valve during LV ejection introduced by Garcia et al. [20] This formulation
expresses the instantaneous net pressure gradient across the AS as a function of the instanta-
neous flow rate and the energy loss coefficient.
TPGnet ¼
2pr
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ELCo
p @QðtÞ
@t
þ r
2ELCo2
Q2ðtÞ ð3Þ
and
ELCo ¼
ðEOAÞA
A EOA ð4Þ
Where ELCo, EOA, A, ρ and Q are the valvular energy loss coefﬁcient, the effective oriﬁce area,
ascending aorta cross sectional area, the ﬂuid density and the transvalvular ﬂow rate, respec-
tively. ELCo, introduced by Garcia et al. [20], representing the ‘recovered EOA’, denotes valve
effective oriﬁce area adjusted for the area of the aorta at the level of sinotubular junction.
Therefore, variable aortic valve resistance (Rav) and constant aortic valve inductance (Lav) (Fig
1) in the lumped parameter model are r
2ELCo2
Q and 2prﬃﬃﬃﬃﬃﬃ
ELCo
p , respectively (Eq 3).
Aortic Valve Bypass Model
In a normal heart, total blood flow ejected by the LV, after crossing the aortic valve, is redi-
rected towards the upper-body. However, after the AVB surgery, a portion of the blood flow
ejected by the LV goes towards the AS and the other portion towards the descending aorta
through the bypass conduit. To take this into account in the model, a branch is placed in paral-
lel to the AS (Fig 1). This branch simulates the flow bypassing the AS. Since, no formulation
has been developed to express the net instantaneous pressure gradient through a conduit valve
yet, we elected to use the same formulation as the one used for modeling the stenotic valve (Eq
3). Therefore, this branch includes a constant resistance for conduit tube (RAVB) (Table 1) plus
a time-varying resistance (RAVBv ¼ r2ELCo2 Q), and an inductance (LAVBv ¼
2pr
ﬃﬃﬃﬃﬃﬃ
ELCo
p ) which together
represent the net pressure gradient induced by the conduit valve (Eq 3). The EOA of the con-
duit valve was determined as follows: for a specific bioprosthetic valve size (between 19 and 29
mm), the reported EOAs of all the manufacturers listed in Pibarot et al. [21] were averaged. Yet
a 17 mm valve can also be used for AVB surgery in adult patients. Therefore, the EOA for a
conduit valve of 17 mm was extrapolated from the data reported in Pibarot et al [21].
Computational Algorithm
Here, we provide a succinct description, see Keshavarz-Motamed et al. [16,17] for more details.
The lumped model illustrated in Fig 1 was analyzed numerically by creating and solving a sys-
tem of ordinary differential equations in Matlab Simscape (MathWorks, Inc). Fourier series re-
presentation of experimental normalized elastance curve for human adults introduced by
Senzaki et al. [18] was used to generate a signal as an input into the main program. Simulation
started at the onset of isovolumic contraction. The left ventricle volume V(t) was calculated
using the left ventricle pressure PLV and elastance values using Eq 1. The left ventricle is filled
by a normalized physiological mitral flow waveform adjusted for the total required stroke vol-
ume. The left ventricle flow rate subsequently was calculated as the time derivative of the left
ventricle volume. After few initial cycles, solution converged. Matlab’s “ode23t” trapezoidal
Aortic Valve Bypass Hemodynamics
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rule variable-step solver was used to solve system of differential equations with the initial time
step of 0.1 milliseconds. The convergence residual criterion was set to 10–5. All initial values in-
cluding voltages and currents of capacitors and inductors were set to zero.
Results
Verification of the Lumped Parameter Model using in vivo Published
Data
Verification of the model was done based on the study reported by Stauffer et al. [14] for differ-
ent configurations of the AVB: 1) conduit size (diameter): 18 mm, conduit valve size (diame-
ter): 19 mm; 2) conduit size: 20 mm, conduit valve size: 21 mm; and 3) conduit size: 22 mm,
conduit valve size: 23 mm. Postoperative flow assessments using magnetic resonance imaging
for these configurations show that 65% of the outflow is conducted from the LV apex to the
conduit, while only 35% crosses the AS [14]. The blood flow proportion through a severe AS
with two different severities (EOAs: 0.61 cm2 and 0.7 cm2) and different configurations of con-
duit were calculated using the lumped parameter model developed in this study and compared
to the flow proportion from in vivo data. Data resulting from our mathematical simulations
were consistent with Stauffer et al. findings (range of errors: 0.11% to 8.46%) (see Table 2) [14].
Pre-AVB Surgery: Simulation in the Presence of a Severe AS
Fig 2 shows the LV and aortic waveforms simulated using the current model for: 1) a healthy
aortic valve (no AS: EOA = 4 cm2); 2) severe AS with EOA of 0.7 cm2. As expected, the pres-
ence of a severe AS induces very large transvalvular pressure gradients: TPGmax = 99 mmHg;
TPGmean = 52 mmHg. The results for an EOA of 0.7 cm
2 are displayed because this EOA corre-
sponds to the median value reported in the study of Lund et al. [5] for patients with AVB.
Table 2. Computed AS and AVB flow rate ratio in the presence of fixed severe AS (EOA = 0.7 cm2).
AVB valve size (mm)
AVB conduit
size (mm)
17 19 21 23 25 27 29
18 AV: 40.25%
AVB: 59.74%
AV: 36.57%*
AVB: 63.43%
AV: 34.47%
AVB: 65.53%
AV: 32.79%
AVB: 67.21%
AV: 31.45%
AVB: 68.56%
AV: 31% AVB:
69%
AV: 30.57%
AVB: 69.43%
20 AV: 41.68%
AVB: 58.32%
AV: 37.97%
AVB: 62.03%
AV: 35.82%*
AVB: 64.18%
AV: 33.99%
AVB: 66.01%
AV: 32.43%
AVB: 67.57%
AV: 31.86%
AVB: 68.14%
AV: 31.32%
AVB: 68.68%
22 AV: 42.70%
AVB: 57.30%
AV: 39.02%
AVB: 60.98%
AV: 36.84%
AVB: 66.16%
AV: 34.96%*
AVB: 65.04%
AV: 32.28%
AVB: 66.72%
AV: 32.63%
AVB: 67.36%
AV: 32% AVB:
68%
24 AV: 43.48%
AVB: 56.52%
AV: 39.84%
AVB: 60.16%
AV: 37.66%
AVB: 62.33%
AV: 35.72%
AVB: 64.28%
AV: 33.97%
AVB: 66.03%
AV: 33.28%
AVB: 66.72%
AV: 32.6% AVB:
67.4%
26 AV: 44.07%
AVB: 55.93%
AV: 40.45%
AVB: 59.55%
AV: 38.25%
AVB: 61.73%
AV: 36.33%
AVB: 63.67%
AV: 34.53%
AVB: 65.47%
AV: 33.83%
AVB: 66.17%
AV: 33.11%
AVB: 66.9%
28 AV: 44.53%
AVB: 55.47%
AV: 40.95%
AVB: 59.05%
AV: 38.77%
AVB: 61.23%
AV: 36.81%
AVB: 63.19%
AV: 34.99%
AVB: 65%
AV: 34.26%
AVB: 65.74%
AV: 33.53%
AVB: 66.47%
*Relative error in computed ﬂow rates through native valve with EOA of 0.7 cm2 and AVB with combinations of 18–19, 20–21 and 22–23, compared to the
results reported by Stauffer et al. (2011) are 4.49%, 2.34% and 0.11%, respectively. AV: aortic valve; AVB: aortic valve bypass
Stroke volume, heart rate and cardiac output are 75 ml, 70 beats/min and 5.2 l/min, respectively. AV: aortic valve, AVB: aortic valve bypass
doi:10.1371/journal.pone.0123000.t002
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Fig 2. Simulated left ventricle and aorta pressures. (A) Healthy (No AS & No AVB), (B) severe AS
(EOA = 0.7 cm2) & No AVB. Stroke volume, heart rate and cardiac output are 75 ml, 70 beats/min and 5.2 l/
min, respectively.
doi:10.1371/journal.pone.0123000.g002
Aortic Valve Bypass Hemodynamics
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Post- AVB Surgery: Simulation in the Presence of AS and AVB
Fig 3a and 3b show the computed LV and aortic waveforms after the AVB surgery for the AS
with an EOA of 0.7 cm2. Here the results for an AVB with a conduit valve size of 19 mm and
two different conduit sizes (18 mm and 26 mm) are displayed. The AVB induced a significant
reduction in LV peak pressure and TPGs that can be reduced down from 99 mmHg (Fig 2b)
to 28/25 mmHg (Fig 3a and 3b) for TPGmax and from 52 mmHg (Fig 2b) to 17/15 mmHg
Fig 3. Simulated left ventricle and aorta pressures and flow distribution. (A) Severe AS (EOA = 0.7 cm2) & AVB (conduit valve size: 19 mm, conduit
size: 18mm), (B) severe AS (EOA = 0.7 cm2) & AVB (conduit valve size: 19 mm, conduit size: 26mm). Stroke volume, heart rate and cardiac output are 75 ml,
70 beats/min and 5.2 l/min, respectively.
doi:10.1371/journal.pone.0123000.g003
Aortic Valve Bypass Hemodynamics
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(Fig 3a and 3b) for TPGmean. Moreover, Fig 3 shows the calculated flow rate distribution be-
tween the AS and the AVB. A LV with an AVB with a conduit valve size of 19 mm and a con-
duit size of 18 mm is expected to eject 36.57% of the total flow rate through the AS and 63.43%
through the bypass. Now, if a conduit size of 26 mm is used with the same conduit valve size,
flow distribution changes slightly: 40.45% through the AS and 59.55% through the AVB.
Flow Distribution after AVB
Table 2 represents the flow distribution between the AVB and the aortic valve predicted using
the lumped parameter model for EOA = 0.7 cm2. Here several possible combinations of con-
duit valve size and conduit size are considered. For an AS with EOA = 0.7 cm2, the percentage
of the total flow crossing the aortic valve ranges from 30.57% to 44.53% (mean value: 36%).
Left Ventricle Stroke Work after AVB
Fig 4 shows the reduction in LV stroke work following the AVB surgery. The LV has to develop
a stroke work of 1.82 J in order to overcome the overload imposed by a severe AS with an EOA
of 0.7 cm2 (Fig 4a). Now with an AVB with a conduit valve size of 19 mm and a conduit size of
18 mm, the LV stroke work is significantly reduced to 1.19 J (-0.63 J; -34%) (Fig 4b). A larger
conduit size of 26 mm leads to small variations in LV stroke work compared to a 18 mm con-
duit (1.21 J vs.1.19 J).
Fig 4c shows the reduction in LV stroke work following the AVB surgery for several AS se-
verities (EOA range: 0.55 cm2 to 0.75 cm2). LV stroke work values corresponding to the AVB
for each AS severity were averaged over all configurations of conduit valve size and conduit
size tested in this study. For all AS severities, the AVB contributed to a significant reduction in
the LV stroke work. The LV stroke work values reached following the AVB surgery are not sig-
nificantly affected by the selected conduit valve size/conduit size configurations for the AVB
and reached a value around 1.2 J. This value remains however higher than normal LV stroke
work values (1.03 J).
Discussion
We have introduced a lumped-parameter method which captures the interaction between left
ventricle, AS, arterial system, and AVB. This method only needs few non-invasively measured
quantities described as follows: 1) total stroke volume; 2) EOA of the aortic valve and aortic
cross sectional area (A); (3) EOA of the conduit valve and conduit area. All the above men-
tioned parameters can easily be measured in patients non-invasively [17,22]. The key findings
of this study are the followings: 1) the AVB leads to a significant reduction in transvalvular
pressure gradient; 2) the conduit valve size, compared to the conduit size, has more effect on
flow distribution between the AS and the AVB; 3) The flow distribution between the AS and
the AVB can be predicted mathematically using non-invasive patient data; 4) the AVB leads to
a significant reduction in LV stroke work.
AVB is not a new technique, the first reference to AVB was in 1910 [23] and in 1995 [24],
used in animals. This was also followed by its implantation in human by Templeton in 1962
(unpublished work). However, as its development was in the same period of prosthetic heart
valves, the success of the AVR reduced temporarily the interests in the AVB. But, with the ex-
pected increasing number of high-risk patients with severe symptomatic AS and contraindica-
tion to the AVR (due to comorbidities, calcified aorta or narrow LVOT), alternative strategies
have to be developed or revived.
TAVI seems to be a very attractive option for such inoperable patients. However, TAVI
may be complicated if performed in patients with calcified aorta (expect for the apical
Aortic Valve Bypass Hemodynamics
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Fig 4. Simulated LV stroke work. (A) Pre-AVB surgery for a severe AS (EOA = 0.7 cm2), (B) post-AVB surgery with a conduit valve size of 19 mm and a
conduit size of 18mm, (C) LV stroke work variations with and without AVB for different AS severities. The values are averaged over the all configurations for
AVB in terms of conduit and valves sizes simulated in this study.
doi:10.1371/journal.pone.0123000.g004
Aortic Valve Bypass Hemodynamics
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approach), ostial encroachment or bicuspid valve. In a recent study, Garcia et al. [25] showed
that around 25% of patients with AS have a bicuspid valve. As a consequence, there will always
exist a sub-population of ‘no-option’ patients. For such patients, the AVB, using the new devel-
oped device by Correx Inc., can be an interesting option for such patients since the aortic valve
and the aorta remain undisturbed. As a consequence, this limits significantly the risks of stroke
and thromboembolism [10,26]. Furthermore, since the prosthetic valve is located inside the
conduit, it is not subjected to prosthesis-patient mismatch restrictions [27].
In this study, we showed that the AVB leads to a significant reduction in TPG. It should be
mentioned however that the reduction in the TPG can mainly be attributed to the significant
reduction in the flow rate crossing the aortic valve following the AVB surgery.
This flow distribution is a major determinant of the residual transvalvular pressure gradient
through the native aortic valve following AVB. To determine this ratio, the model developed in
this study needs only non-invasive parameters that are routinely measured in daily clinical
practice and the EOA of the bioprosthetic valve in the conduit (listed in Pibarot and Dumesnil
[21]). The results, using the current model, show that the flow through the conduit may repre-
sent between 55.47% and 72.1% of the total flow rate depending on the EOA of the AS, the
EOA of the conduit valve and the size of the conduit. The most important determinant of the
flow distribution is the conduit valve size (in this study: R = 0.84, p<0.01). The results obtained
in this study are consistent with previous in vivo and in silico studies [6,10,26].
Another significant result found in this study is that the AVB significantly reduces the LV
stroke work. The expected post-operative LV stroke work is appeared to be quite independent
from the selected AVB configurations. Interestingly, it has been hypothesized that the AVB
might provide better overall hemodynamic performance since the net effective orifice area
should be the summation of the effective orifice area of the stenotic aortic valve plus the effective
orifice area of the bioprosthetic valve included in the conduit [5]. Our results show that the LV
stroke work values obtained following the AVB surgery are statistically significantly higher than
those expected by simply adding up the conduit valve EOA and the aortic valve EOA (1.19±0.03
J vs. 1.10±0.05 J, p<0.001). However, the differences appear not to be clinically significant.
Limitations
Since no formulation has been developed to express the net instantaneous pressure gradient
through a conduit valve yet, we elected to use the same formulation as the one used for model-
ing the aortic valve. In order to assess the validity of this formulation, data resulting from our
mathematical simulations were compared with in vivo findings (Stauffer et al. [14]), resulted to
good agreements between them (range of errors: 0.11% to 8.46%). However, more in vivo and
in vivo studies are still required to determine further the validity of the equation mainly for
large conduit valve sizes.
Conclusions
AVB is a viable solution for patients with AS and contraindications to both AVR and TAVI.
AVB leads to a double outlet LV. In this study, we have shown by using mathematical model-
ling that AVB leads to a significant reduction in pressure gradient across the AS and LV stroke
work. Furthermore, the results show that the flow distribution (through AS vs. AVB) can be
predicted mathematically and its main determinant is conduit valve size. Finally, AVB leads a
significant reduction in LV stroke work whatever is the configuration of conduit valve size and
conduit size. Finally, the positive hemodynamic results obtained in this study following AVB
may suggest a need for a randomized trial comparing TAVI and AVB.
Aortic Valve Bypass Hemodynamics
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